nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—ABCB1—peripheral nervous system neoplasm	0.332	1	CbGaD
Amsacrine—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.127	0.287	CbGbCtD
Amsacrine—TOP2A—Etoposide—peripheral nervous system neoplasm	0.0989	0.223	CbGbCtD
Amsacrine—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.0675	0.152	CbGbCtD
Amsacrine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0338	0.0763	CbGbCtD
Amsacrine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0338	0.0763	CbGbCtD
Amsacrine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0234	0.0529	CbGbCtD
Amsacrine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0144	0.0326	CbGbCtD
Amsacrine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0135	0.0304	CbGbCtD
Amsacrine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0132	0.0299	CbGbCtD
Amsacrine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00902	0.0204	CbGbCtD
Amsacrine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0085	0.0192	CbGbCtD
Amsacrine—NCOA3—Validated nuclear estrogen receptor beta network—SMARCB1—peripheral nervous system neoplasm	0.0065	0.223	CbGpPWpGaD
Amsacrine—NCOA3—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00279	0.516	CbGdCrCtD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—MXI1—peripheral nervous system neoplasm	0.00239	0.0821	CbGpPWpGaD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.00128	0.0441	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.00126	0.0432	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—COX2—peripheral nervous system neoplasm	0.000932	0.032	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 1—AURKA—peripheral nervous system neoplasm	0.000921	0.0317	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.000856	0.0294	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000804	0.0276	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.000776	0.0267	CbGpPWpGaD
Amsacrine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000588	0.0202	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000561	0.0193	CbGpPWpGaD
Amsacrine—NCOA3—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.000546	0.101	CbGdCrCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—AURKA—peripheral nervous system neoplasm	0.00053	0.0182	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000524	0.018	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000511	0.0176	CbGpPWpGaD
Amsacrine—NCOA3—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.0932	CbGdCrCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000502	0.0172	CbGpPWpGaD
Amsacrine—NCOA3—Retinoic acid receptors-mediated signaling—AKT1—peripheral nervous system neoplasm	0.000413	0.0142	CbGpPWpGaD
Amsacrine—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000384	0.0708	CbGdCrCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000372	0.0128	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000337	0.0116	CbGpPWpGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.000325	0.0112	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.000276	0.00948	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—peripheral nervous system neoplasm	0.000269	0.00924	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000256	0.00879	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—MYC—peripheral nervous system neoplasm	0.000254	0.00874	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000232	0.00796	CbGpPWpGaD
Amsacrine—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000228	0.0421	CbGdCrCtD
Amsacrine—NCOA3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000228	0.00783	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—ERBB2—peripheral nervous system neoplasm	0.000218	0.00749	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000212	0.00729	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000209	0.00719	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—TP53—peripheral nervous system neoplasm	0.000209	0.00717	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000189	0.0065	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000182	0.00627	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000179	0.00616	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000173	0.00594	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000173	0.00594	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000166	0.00571	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GNS—peripheral nervous system neoplasm	0.000165	0.00566	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000163	0.00561	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.00016	0.00548	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NME1—peripheral nervous system neoplasm	0.000158	0.00542	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000152	0.00523	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—COX2—peripheral nervous system neoplasm	0.000152	0.00522	CbGpPWpGaD
Amsacrine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.000797	CcSEcCtD
Amsacrine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.000791	CcSEcCtD
Amsacrine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00015	0.000791	CcSEcCtD
Amsacrine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00015	0.000788	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00015	0.00514	CbGpPWpGaD
Amsacrine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000149	0.000784	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000783	CcSEcCtD
Amsacrine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000149	0.000782	CcSEcCtD
Amsacrine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000148	0.00078	CcSEcCtD
Amsacrine—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000777	CcSEcCtD
Amsacrine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000147	0.000774	CcSEcCtD
Amsacrine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000147	0.000774	CcSEcCtD
Amsacrine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000147	0.000771	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000146	0.00502	CbGpPWpGaD
Amsacrine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000146	0.000768	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000766	CcSEcCtD
Amsacrine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.000765	CcSEcCtD
Amsacrine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000144	0.00076	CcSEcCtD
Amsacrine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000144	0.000759	CcSEcCtD
Amsacrine—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000758	CcSEcCtD
Amsacrine—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000144	0.0265	CbGdCrCtD
Amsacrine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000144	0.000756	CcSEcCtD
Amsacrine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000144	0.000756	CcSEcCtD
Amsacrine—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000144	0.0265	CbGdCrCtD
Amsacrine—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000144	0.0265	CbGdCrCtD
Amsacrine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000143	0.000751	CcSEcCtD
Amsacrine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000143	0.00075	CcSEcCtD
Amsacrine—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000748	CcSEcCtD
Amsacrine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000746	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000142	0.00487	CbGpPWpGaD
Amsacrine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000142	0.000744	CcSEcCtD
Amsacrine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000142	0.000744	CcSEcCtD
Amsacrine—Rash—Topotecan—peripheral nervous system neoplasm	0.000141	0.000744	CcSEcCtD
Amsacrine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000141	0.000743	CcSEcCtD
Amsacrine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000141	0.000743	CcSEcCtD
Amsacrine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000141	0.00074	CcSEcCtD
Amsacrine—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00074	CcSEcCtD
Amsacrine—Headache—Topotecan—peripheral nervous system neoplasm	0.000141	0.000739	CcSEcCtD
Amsacrine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00014	0.000738	CcSEcCtD
Amsacrine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00014	0.000738	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00014	0.000738	CcSEcCtD
Amsacrine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00014	0.000738	CcSEcCtD
Amsacrine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00014	0.000737	CcSEcCtD
Amsacrine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00014	0.000737	CcSEcCtD
Amsacrine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00014	0.000737	CcSEcCtD
Amsacrine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00014	0.000735	CcSEcCtD
Amsacrine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00014	0.000735	CcSEcCtD
Amsacrine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00014	0.000734	CcSEcCtD
Amsacrine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000139	0.000733	CcSEcCtD
Amsacrine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000139	0.000733	CcSEcCtD
Amsacrine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.000731	CcSEcCtD
Amsacrine—Pain—Vincristine—peripheral nervous system neoplasm	0.000139	0.000731	CcSEcCtD
Amsacrine—Rash—Melphalan—peripheral nervous system neoplasm	0.000139	0.000729	CcSEcCtD
Amsacrine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000138	0.000728	CcSEcCtD
Amsacrine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.000725	CcSEcCtD
Amsacrine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000721	CcSEcCtD
Amsacrine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000719	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000136	0.000717	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000711	CcSEcCtD
Amsacrine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000134	0.000706	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000134	0.00461	CbGpPWpGaD
Amsacrine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000134	0.000705	CcSEcCtD
Amsacrine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.000705	CcSEcCtD
Amsacrine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.000701	CcSEcCtD
Amsacrine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.000701	CcSEcCtD
Amsacrine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000133	0.000701	CcSEcCtD
Amsacrine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000133	0.000699	CcSEcCtD
Amsacrine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000133	0.000698	CcSEcCtD
Amsacrine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000132	0.000695	CcSEcCtD
Amsacrine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000132	0.000695	CcSEcCtD
Amsacrine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000692	CcSEcCtD
Amsacrine—Infection—Etoposide—peripheral nervous system neoplasm	0.000131	0.000688	CcSEcCtD
Amsacrine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000131	0.000686	CcSEcCtD
Amsacrine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000131	0.000686	CcSEcCtD
Amsacrine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000685	CcSEcCtD
Amsacrine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000683	CcSEcCtD
Amsacrine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000679	CcSEcCtD
Amsacrine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000129	0.000678	CcSEcCtD
Amsacrine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000129	0.000676	CcSEcCtD
Amsacrine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000129	0.000676	CcSEcCtD
Amsacrine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000129	0.000676	CcSEcCtD
Amsacrine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000128	0.000674	CcSEcCtD
Amsacrine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000128	0.000673	CcSEcCtD
Amsacrine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000126	0.00066	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000658	CcSEcCtD
Amsacrine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000657	CcSEcCtD
Amsacrine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000125	0.000655	CcSEcCtD
Amsacrine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.000654	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000653	CcSEcCtD
Amsacrine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000648	CcSEcCtD
Amsacrine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000123	0.000647	CcSEcCtD
Amsacrine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000123	0.000646	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000123	0.00421	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MET—peripheral nervous system neoplasm	0.000122	0.0042	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000121	0.00417	CbGpPWpGaD
Amsacrine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.000637	CcSEcCtD
Amsacrine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000632	CcSEcCtD
Amsacrine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00012	0.00063	CcSEcCtD
Amsacrine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000623	CcSEcCtD
Amsacrine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000118	0.000622	CcSEcCtD
Amsacrine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000621	CcSEcCtD
Amsacrine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000618	CcSEcCtD
Amsacrine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000117	0.000617	CcSEcCtD
Amsacrine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000117	0.000613	CcSEcCtD
Amsacrine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000609	CcSEcCtD
Amsacrine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000609	CcSEcCtD
Amsacrine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000116	0.000608	CcSEcCtD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000116	0.00397	CbGpPWpGaD
Amsacrine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000115	0.000607	CcSEcCtD
Amsacrine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000115	0.000603	CcSEcCtD
Amsacrine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000114	0.000602	CcSEcCtD
Amsacrine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.0006	CcSEcCtD
Amsacrine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000598	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000114	0.000598	CcSEcCtD
Amsacrine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000598	CcSEcCtD
Amsacrine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000114	0.000597	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000113	0.00389	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000113	0.00388	CbGpPWpGaD
Amsacrine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000593	CcSEcCtD
Amsacrine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000593	CcSEcCtD
Amsacrine—Pain—Etoposide—peripheral nervous system neoplasm	0.000113	0.000592	CcSEcCtD
Amsacrine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000112	0.000587	CcSEcCtD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000111	0.00383	CbGpPWpGaD
Amsacrine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000111	0.000585	CcSEcCtD
Amsacrine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00058	CcSEcCtD
Amsacrine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000576	CcSEcCtD
Amsacrine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000575	CcSEcCtD
Amsacrine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000571	CcSEcCtD
Amsacrine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000109	0.000571	CcSEcCtD
Amsacrine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000108	0.000568	CcSEcCtD
Amsacrine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000568	CcSEcCtD
Amsacrine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000108	0.000566	CcSEcCtD
Amsacrine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000108	0.000565	CcSEcCtD
Amsacrine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000564	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000107	0.00368	CbGpPWpGaD
Amsacrine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000563	CcSEcCtD
Amsacrine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000563	CcSEcCtD
Amsacrine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000106	0.000559	CcSEcCtD
Amsacrine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000106	0.000559	CcSEcCtD
Amsacrine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000557	CcSEcCtD
Amsacrine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000556	CcSEcCtD
Amsacrine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000106	0.000556	CcSEcCtD
Amsacrine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000554	CcSEcCtD
Amsacrine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000105	0.00055	CcSEcCtD
Amsacrine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000549	CcSEcCtD
Amsacrine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000549	CcSEcCtD
Amsacrine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000549	CcSEcCtD
Amsacrine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000104	0.000547	CcSEcCtD
Amsacrine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000104	0.000547	CcSEcCtD
Amsacrine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000546	CcSEcCtD
Amsacrine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000546	CcSEcCtD
Amsacrine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000544	CcSEcCtD
Amsacrine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000103	0.000544	CcSEcCtD
Amsacrine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000103	0.000542	CcSEcCtD
Amsacrine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00054	CcSEcCtD
Amsacrine—Rash—Vincristine—peripheral nervous system neoplasm	0.000103	0.000539	CcSEcCtD
Amsacrine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000102	0.000539	CcSEcCtD
Amsacrine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000537	CcSEcCtD
Amsacrine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000537	CcSEcCtD
Amsacrine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000536	CcSEcCtD
Amsacrine—Headache—Vincristine—peripheral nervous system neoplasm	0.000102	0.000536	CcSEcCtD
Amsacrine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000533	CcSEcCtD
Amsacrine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.0001	0.000527	CcSEcCtD
Amsacrine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000526	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ENO2—peripheral nervous system neoplasm	9.97e-05	0.00343	CbGpPWpGaD
Amsacrine—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	9.89e-05	0.0182	CbGdCrCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	9.87e-05	0.00339	CbGpPWpGaD
Amsacrine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	9.84e-05	0.000517	CcSEcCtD
Amsacrine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	9.79e-05	0.000515	CcSEcCtD
Amsacrine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	9.7e-05	0.00051	CcSEcCtD
Amsacrine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.000508	CcSEcCtD
Amsacrine—Nausea—Vincristine—peripheral nervous system neoplasm	9.66e-05	0.000508	CcSEcCtD
Amsacrine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	9.64e-05	0.000507	CcSEcCtD
Amsacrine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.000506	CcSEcCtD
Amsacrine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.000506	CcSEcCtD
Amsacrine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.000503	CcSEcCtD
Amsacrine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000499	CcSEcCtD
Amsacrine—Asthenia—Etoposide—peripheral nervous system neoplasm	9.45e-05	0.000497	CcSEcCtD
Amsacrine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000497	CcSEcCtD
Amsacrine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	9.43e-05	0.000496	CcSEcCtD
Amsacrine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000496	CcSEcCtD
Amsacrine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	9.36e-05	0.000492	CcSEcCtD
Amsacrine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000488	CcSEcCtD
Amsacrine—Alopecia—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000483	CcSEcCtD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	9.14e-05	0.00314	CbGpPWpGaD
Amsacrine—Vomiting—Cisplatin—peripheral nervous system neoplasm	9.14e-05	0.000481	CcSEcCtD
Amsacrine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000479	CcSEcCtD
Amsacrine—Rash—Cisplatin—peripheral nervous system neoplasm	9.06e-05	0.000477	CcSEcCtD
Amsacrine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	9.06e-05	0.000476	CcSEcCtD
Amsacrine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000476	CcSEcCtD
Amsacrine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.01e-05	0.000474	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—ERBB2—peripheral nervous system neoplasm	8.93e-05	0.00307	CbGpPWpGaD
Amsacrine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000469	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—AURKA—peripheral nervous system neoplasm	8.82e-05	0.00303	CbGpPWpGaD
Amsacrine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000459	CcSEcCtD
Amsacrine—Dizziness—Etoposide—peripheral nervous system neoplasm	8.71e-05	0.000458	CcSEcCtD
Amsacrine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.66e-05	0.000456	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	8.63e-05	0.00297	CbGpPWpGaD
Amsacrine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000452	CcSEcCtD
Amsacrine—Nausea—Cisplatin—peripheral nervous system neoplasm	8.54e-05	0.000449	CcSEcCtD
Amsacrine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000448	CcSEcCtD
Amsacrine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.000447	CcSEcCtD
Amsacrine—NCOA3—Metabolism—BCHE—peripheral nervous system neoplasm	8.43e-05	0.0029	CbGpPWpGaD
Amsacrine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000443	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	8.38e-05	0.00288	CbGpPWpGaD
Amsacrine—Vomiting—Etoposide—peripheral nervous system neoplasm	8.37e-05	0.00044	CcSEcCtD
Amsacrine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.00044	CcSEcCtD
Amsacrine—Anaemia—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.00044	CcSEcCtD
Amsacrine—Rash—Etoposide—peripheral nervous system neoplasm	8.3e-05	0.000437	CcSEcCtD
Amsacrine—Dermatitis—Etoposide—peripheral nervous system neoplasm	8.3e-05	0.000436	CcSEcCtD
Amsacrine—Headache—Etoposide—peripheral nervous system neoplasm	8.25e-05	0.000434	CcSEcCtD
Amsacrine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000426	CcSEcCtD
Amsacrine—NCOA3—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.04e-05	0.00276	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—TH—peripheral nervous system neoplasm	7.92e-05	0.00272	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CHEK2—peripheral nervous system neoplasm	7.89e-05	0.00271	CbGpPWpGaD
Amsacrine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000415	CcSEcCtD
Amsacrine—Convulsion—Epirubicin—peripheral nervous system neoplasm	7.84e-05	0.000412	CcSEcCtD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	7.83e-05	0.00269	CbGpPWpGaD
Amsacrine—Nausea—Etoposide—peripheral nervous system neoplasm	7.82e-05	0.000411	CcSEcCtD
Amsacrine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000407	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000402	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	7.6e-05	0.00261	CbGpPWpGaD
Amsacrine—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	7.5e-05	0.0138	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	7.5e-05	0.0138	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	7.5e-05	0.0138	CbGdCrCtD
Amsacrine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.000394	CcSEcCtD
Amsacrine—Confusional state—Epirubicin—peripheral nervous system neoplasm	7.44e-05	0.000391	CcSEcCtD
Amsacrine—Infection—Epirubicin—peripheral nervous system neoplasm	7.33e-05	0.000386	CcSEcCtD
Amsacrine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.000381	CcSEcCtD
Amsacrine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.00038	CcSEcCtD
Amsacrine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000379	CcSEcCtD
Amsacrine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	7.17e-05	0.000377	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	7.08e-05	0.000372	CcSEcCtD
Amsacrine—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.00037	CcSEcCtD
Amsacrine—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	6.94e-05	0.0128	CbGdCrCtD
Amsacrine—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	6.94e-05	0.0128	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	6.94e-05	0.0128	CbGdCrCtD
Amsacrine—Hypotension—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.000363	CcSEcCtD
Amsacrine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000362	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—NRAS—peripheral nervous system neoplasm	6.8e-05	0.00234	CbGpPWpGaD
Amsacrine—Infection—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.000357	CcSEcCtD
Amsacrine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000352	CcSEcCtD
Amsacrine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000351	CcSEcCtD
Amsacrine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	6.63e-05	0.000349	CcSEcCtD
Amsacrine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000349	CcSEcCtD
Amsacrine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.58e-05	0.000346	CcSEcCtD
Amsacrine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000342	CcSEcCtD
Amsacrine—NCOA3—Metabolism—GNAS—peripheral nervous system neoplasm	6.47e-05	0.00222	CbGpPWpGaD
Amsacrine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000337	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	6.4e-05	0.0022	CbGpPWpGaD
Amsacrine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000336	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000335	CcSEcCtD
Amsacrine—Fatigue—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000335	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ABCB1—peripheral nervous system neoplasm	6.35e-05	0.00218	CbGpPWpGaD
Amsacrine—Pain—Epirubicin—peripheral nervous system neoplasm	6.31e-05	0.000332	CcSEcCtD
Amsacrine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.000323	CcSEcCtD
Amsacrine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	0.00032	CcSEcCtD
Amsacrine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.08e-05	0.00032	CcSEcCtD
Amsacrine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.000317	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	6e-05	0.00206	CbGpPWpGaD
Amsacrine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000312	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.94e-05	0.00204	CbGpPWpGaD
Amsacrine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.00031	CcSEcCtD
Amsacrine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.00031	CcSEcCtD
Amsacrine—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.86e-05	0.000308	CcSEcCtD
Amsacrine—Pain—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000307	CcSEcCtD
Amsacrine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.000307	CcSEcCtD
Amsacrine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.000307	CcSEcCtD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	5.8e-05	0.00199	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	5.72e-05	0.00197	CbGpPWpGaD
Amsacrine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000296	CcSEcCtD
Amsacrine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000294	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	5.47e-05	0.00188	CbGpPWpGaD
Amsacrine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000286	CcSEcCtD
Amsacrine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000285	CcSEcCtD
Amsacrine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000284	CcSEcCtD
Amsacrine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000284	CcSEcCtD
Amsacrine—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.3e-05	0.000279	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	5.07e-05	0.00174	CbGpPWpGaD
Amsacrine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.05e-05	0.000266	CcSEcCtD
Amsacrine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000265	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	5.01e-05	0.00172	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.97e-05	0.00171	CbGpPWpGaD
Amsacrine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.9e-05	0.000258	CcSEcCtD
Amsacrine—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000257	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.87e-05	0.00168	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.87e-05	0.00167	CbGpPWpGaD
Amsacrine—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.69e-05	0.000247	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.68e-05	0.00161	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	4.68e-05	0.00161	CbGpPWpGaD
Amsacrine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000246	CcSEcCtD
Amsacrine—Rash—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.000245	CcSEcCtD
Amsacrine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.000245	CcSEcCtD
Amsacrine—Headache—Epirubicin—peripheral nervous system neoplasm	4.62e-05	0.000243	CcSEcCtD
Amsacrine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.59e-05	0.00158	CbGpPWpGaD
Amsacrine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000238	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.39e-05	0.00151	CbGpPWpGaD
Amsacrine—Nausea—Epirubicin—peripheral nervous system neoplasm	4.38e-05	0.000231	CcSEcCtD
Amsacrine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.34e-05	0.000228	CcSEcCtD
Amsacrine—Rash—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000226	CcSEcCtD
Amsacrine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000226	CcSEcCtD
Amsacrine—Headache—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.000225	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	4.24e-05	0.00146	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.12e-05	0.00141	CbGpPWpGaD
Amsacrine—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000213	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	3.79e-05	0.0013	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—HRAS—peripheral nervous system neoplasm	3.32e-05	0.00114	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.29e-05	0.00113	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.17e-05	0.00109	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.1e-05	0.00106	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	2.87e-05	0.000987	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.76e-05	0.000948	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MYC—peripheral nervous system neoplasm	2.57e-05	0.000883	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.5e-05	0.00086	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.48e-05	0.000852	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.38e-05	0.000817	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.28e-05	0.000783	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	2.24e-05	0.00077	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.19e-05	0.000754	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	2.15e-05	0.000738	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—peripheral nervous system neoplasm	2.11e-05	0.000725	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	2.07e-05	0.00071	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.99e-05	0.000685	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.95e-05	0.000672	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKT1—peripheral nervous system neoplasm	1.75e-05	0.0006	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.61e-05	0.000552	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.44e-05	0.000495	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.36e-05	0.000466	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.36e-05	0.000466	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.22e-05	0.000418	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.16e-05	0.000399	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.15e-05	0.000394	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.14e-05	0.000393	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.09e-05	0.000376	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.08e-05	0.00037	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	9.34e-06	0.000321	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	8.8e-06	0.000302	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	8.63e-06	0.000297	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.52e-06	8.66e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.38e-06	8.16e-05	CbGpPWpGaD
